Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ENTrigue Surgical developed and commercialized a portfolio of innovative devices for ear, nose, and throat surgeries. Its products included articulating instruments for minimally invasive access, balloon sinus dilation systems, resorbable septal staplers, hemostatic gels, and bioabsorbable implants. The company’s technologies were designed to improve surgical precision and patient outcomes in ENT procedures. At the time of its acquisition by ArthroCare in 2013 for $45 million, several products were already on the market in the US and internationally[1][6][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ENTrigue Surgical.